chr21-46132253-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The ENST00000300527.9(COL6A2):c.2761G>A(p.Val921Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000785 in 1,605,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V921L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000300527.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.2761G>A | p.Val921Met | missense_variant | 28/28 | ENST00000300527.9 | NP_001840.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.2761G>A | p.Val921Met | missense_variant | 28/28 | 1 | NM_001849.4 | ENSP00000300527 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152222Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000897 AC: 21AN: 234188Hom.: 0 AF XY: 0.0000624 AC XY: 8AN XY: 128304
GnomAD4 exome AF: 0.0000654 AC: 95AN: 1453182Hom.: 0 Cov.: 35 AF XY: 0.0000609 AC XY: 44AN XY: 722960
GnomAD4 genome AF: 0.000203 AC: 31AN: 152340Hom.: 0 Cov.: 34 AF XY: 0.000175 AC XY: 13AN XY: 74486
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 01, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 03, 2013 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 10, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.2761G>A (p.V921M) alteration is located in exon 28 (coding exon 27) of the COL6A2 gene. This alteration results from a G to A substitution at nucleotide position 2761, causing the valine (V) at amino acid position 921 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Bethlem myopathy 1A Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 26, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at